BRAF and cardiofaciocutaneous syndrome 1: Conversely, CFCS is genetically heterogeneous and caused by heterozygous activating mutations in the BRAF, MAP2K1, MAP2K2 and KRAS genes, leading to a more variable clinical presentation [4].